RSS   Newsletter   Contact   Advertise with us

Germany grants BioNTech, CureVac $745 million to speed up coronavirus vaccine work

Christian Fernsby ▼ | September 16, 2020
Germany awarded $745 million in funding to BioNTech and CureVac on Tuesday to speed up work on coronavirus vaccines and expand German production capacity.
BioNTech
Germany   BioNTech
esearch Minister Anja Karliczek stressed that safety should remain the utmost priority to ensure vaccines will be accepted by the broader population.

Topics: Germany BioNTech CureVac

“Even when the world is waiting for a vaccine we won’t take risky short cuts here,” she told a news conference in Berlin.

Karliczek said she does not expect a vaccine to be available for the broader population until the middle of 2021.


 

MORE INSIDE POST